MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 123 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 11.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,214 | +1.4% | 13,270 | +21.5% | 0.04% | -13.3% |
| Q4 2022 | $3,169 | -99.6% | 10,919 | +13.9% | 0.04% | +800.0% |
| Q4 2021 | $812,000 | -22.5% | 9,589 | -10.9% | 0.01% | -50.0% |
| Q2 2021 | $1,048,000 | +25.8% | 10,759 | +53.3% | 0.01% | -58.3% |
| Q3 2020 | $833,000 | +129.5% | 7,019 | +66.4% | 0.02% | +41.2% |
| Q3 2019 | $363,000 | – | 4,217 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |